Evogene (EVGN) - היקף יתרות מזומנים למניה

Evogene Ltd. monetizes its Scalability AI platform by creating digital genome models for the agricultural sector through licensing royalties. The GURU.Markets terminal displays a chart of high-liquid assets per share, where 0.52 reflects the latest metric value. Liquidity dynamics are critical amid Israeli geopolitical risks and global demand for crop yields, as well as growing interest among biotech companies in R&D optimization.
פילוחי מדדים מקיפים ואנליטיקה עבור Evogene Ltd (EVGN)

This metric determines the liquid value of a single share, reflecting the company's actual cash reserves. By analyzing current cash per share, an investor assesses internal financial stability and capital protection. The metric is calculated by dividing the total amount of cash by the number of issued securities. A high level of liquidity guarantees Evogene Ltd. (EVGN) stable funding for its IT infrastructure, which is critical for the uninterrupted operation of cloud computing during the development of AI platforms.